Sunday, November 22, 2026
Home Blog Page 1386

Hydroxychloroquine has helped COVID-19 patients: Study

Representational Image

New Delhi (NVI): The antimalarial drug Hydroxychloroquine (HCQ) has helped COVID-19 patients survive better, according to a new study.

A team at Henry Ford Health System said their study of 2,541 hospitalized patients found that those given Hydroxychloroquine were 50 percent less likely to die of the brutal infection than those who did not receive the drug, the CNN reported.

Division head of Henry Ford Health System, Dr Marcus Zervos, said 26 per cent of those not given Hydroxychloroquine died, compared to 13 per cent of those who got the drug. The team looked back at everyone treated in the hospital system since the first patient in March, the report said.

According to the new study, published in the International Journal of Infectious Diseases reports, “Overall crude mortality rates were 18.1 per cent in the entire cohort, 13.5 per cent in the Hydroxychloroquine alone group, 20.1 per cent among those receiving Hydroxychloroquine plus Azithromycin, 22.4 per cent among the Azithromycin alone group, and 26.4 per cent for neither drug,”

The Henry Ford team monitored patients carefully for heart problems. “The combination of Hydroxychloroquine plus Azithromycin was reserved for selected patients with severe COVID-19 and with minimal cardiac risk factors,” the team wrote.

The team said they believe their findings show hydroxychloroquine could be potentially useful as a treatment for coronavirus, the CNN report said.

“It’s important to note that in the right settings, this potentially could be a lifesaver for patients,” Dr. Steven Kalkanis, CEO of the Henry Ford Medical Group, said at the news conference.

However, it is a surprising finding because several other studies have found no benefit from Hydroxychloroquine, a drug originally developed to treat and prevent malaria, mostly in countries like India.

It comes after several large-scale studies found no benefit from the malaria drug, touted by US President Donald Trump, which prompted the US Food and Drug Administration (FDA) to revoke its emergency use authorization for the drug including trials sponsored by the World Health Organization and the National Institutes of Health, were halted.

But later studies found not only did patients not do better if they got the drug, they were more likely to suffer cardiac side effects

Meanwhile, researchers not involved in the Henry Ford study pointed out it wasn’t of the same quality of the studies showing hydroxychloroquine did not help patients, and said other treatments, such as the use of the steroid dexamethasone, might have accounted for the better survival of some patients, the CNN said.

“Our results do differ from some other studies,” Zervos told in a news conference. “What we think was important in ours … is that patients were treated early. For hydroxychloroquine to have a benefit, it needs to begin before the patients begin to suffer some of the severe immune reactions that patients can have with Covid,” he added.

Steven Kalkanis, chief executive officer of the Henry Ford Medical Group said that their findings do not necessarily contradict those of earlier studies. “We also want to make the point that just because our results differ from some others that may have been published, it doesn’t make those studies wrong or definitely a conflict.”

“Much more work needs to be done to elucidate what the final treatment plan should be for Covid-19,” adding that Hydroxychloroquine can help interfere with the virus directly and also reduces inflammation.

However, researchers who were not involved with the study were critical. They noted that the Henry Ford team did not randomly treat patients but selected them for various treatments based on certain criteria.

“As the Henry Ford Health System became more experienced in treating patients with COVID-19, survival may have improved, regardless of the use of specific therapies,” Dr Todd Lee of the Royal Victoria Hospital in Montreal, Canada, in a commentary that accompanied the study.

Likewise, the United Kingdom COVID-19 trial ends hydroxychloroquine study because there’s no evidence the drug benefits patients. As the Detroit paper excluded 267 patients — nearly 10 per cent of the study population —who had not yet been discharged from the hospital.

Both the Detroit and New York studies were observational, they looked back at how patients did when doctors prescribed hydroxychloroquine.

These observational studies are not as valuable as controlled clinical trials while considered the gold standard in medicine, patients in a clinical trial are randomly assigned to take either the drug or a placebo, which is a treatment that does nothing.

Two clinical trials on hydroxychloroquine for COVID-19, one in the US and one in the UK, were stopped early because their data suggested hydroxychloroquine wasn’t helpful.

The US trial, run by the National Institutes of Health, enrolled more than 470 patients while in UK trial, run by the University of Oxford, enrolled more than 11,000 patients.

According to Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, science shows hydroxychloroquine is not effective as a coronavirus treatment.

“We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalized with COVID-19,” the Oxford doctors concluded.

But a White House official praised the Henry Ford team’s study. Peter Navarro, the White House trade adviser, said the study shows hydroxychloroquine works if given early enough.

“This is a big deal. This medicine can literally save tens of thousands, perhaps hundreds of thousands of American lives and maybe millions of people worldwide,” he added.

-RJV

Odisha’s Paradip Port emerge as number one for cargo handling in the country

Paradip Port Trust, Odisha

Subrat Kumar Sarangi

Bhubaneswar (NVI): Paradip Port Trust (PPT) in Jagatsinghpur district of Odisha has become the number one major port in India by handling 25.73 million metric tonnes cargo during April-June 2020.

Despite the maritime industry facing a daunting task to function smoothly due to COVID-19 pandemic which continues to stifle the global chain, the PPT has come out with flying colours and clocked a record 25.73 million metric tonnes cargo handling, according to a statement released by PPT.

Rinkesh Roy, Chairman, PPT and AK Bose, Dy. Chairman, PPT, have conveyed their gratitude to all employees, Unions, State Government, District Administration, Importers, Exporters, Stevedores, Steamer Agents, Port Users and other stakeholders, with whose regular support, a new chapter could be written in the history of the port.

However, the encouragement and guidance shown by the Minister of Shipping, Mansukh Mandviya and Secretary Shipping, Sanjeev Ranjan, helped the port to scale new heights.

-RJV

State-wise details of Covid-19 cases in India

File photo

New Delhi (NVI): India today saw the biggest single-day rise in coronavirus cases of 22,771 in the last 24 hours, taking the the total number of cases to 6,48,315, according to Union Health Ministry data.

Meanwhile, the total number of fatalities due to the deadly contagion rose to 18,655 in the country after 442 new fatalities were reported during this period.

In Maharashtra, the COVID-19 cases increased to 1,92,990, followed by Tamil Nadu with 1,027,21 cases, and Delhi with 94,695 cases.

Total positive cases in States/UTs:

Andaman and Nicobar Islands- 116

Andhra Pradesh- 16,934

Arunachal Pradesh- 252

Assam- 9,673

Bihar- 10,954

Chandigarh- 457

Chhattisgarh- 3,065

Dadar Nagar Haveli- 26

Delhi- 94,695

Gujarat- 34,600

Goa- 1,482

Haryana– 16,003

Himachal Pradesh- 1,033

Jammu and Kashmir- 8,019

Jharkhand- 2,695

Karnataka- 19,710

Kerala- 4,964

Ladakh- 1,001

Madhya Pradesh- 14,297

Maharashtra- 1,92,990

Manipur- 1,316

Meghalaya- 62

Mizoram- 162

Nagaland- 539

Odisha- 8,106

Puducherry- 802

Punjab- 5,937

Rajasthan- 19,052

Sikkim- 102

Tamil Nadu- 1,02,721

Telangana- 20,462

Tripura- 1,525

Uttarakhand- 3,048

Uttar Pradesh- 25,797

West Bengal – 20,488

State/UT wise total death toll:

Andhra Pradesh- 206

Arunachal Pradesh- 1

Assam- 14

Bihar- 80

Chandigarh- 6

Chhattisgarh- 14

Delhi- 2,923

Goa- 4

Gujarat- 1,904

Haryana- 255

Himachal Pradesh- 10

Jammu and Kashmir- 119

Jharkhand- 15

Karnataka- 293

Kerala- 25

Ladakh- 1

Madhya Pradesh- 593

Maharashtra- 8,376

Meghalaya- 1

Odisha- 29

Puducherry- 12

Punjab- 157

Rajasthan- 440

Tamil Nadu- 1,385

Telangana- 283

Tripura- 1

Uttar Pradesh- 749

Uttarakhand- 42

West Bengal- 717

A total of 3,94,227 people have been cured or discharged from hospitals in India. There are around 2,35,433 active cases currently, according to the Health Ministry.

-CHK

PM Modi emphasizes on teachings of Lord Buddha on Ashadha Poornima

Prime Minister Narendra Modi

New Delhi (NVI): Prime Minister Narendra Modi today addressed the nation on Ashadha Poornima and emphasized on the teachings of Lord Buddha.

In an address on the occasion of inauguration of Dharma Chakra Day, PM Modi said that we need to follow the eight-fold path of Lord Buddha for the well-being of society and nation.

“I want to convey my greetings to all on the occasion of Ashadha Poornima today. It is also known as Guru Purnima. This is a day to remember our Gurus, who gave us knowledge. In that spirit, we pay homage to Lord Buddha,” PM Modi said.

PM Modi further added, “The eight-fold path of Lord Buddha shows the way towards the well-being of many societies and nations. It highlights the importance of compassion and kindness. The teachings of Lord Buddha celebrate simplicity both in thought and action.”

The lasting solutions to the extra-ordinary challenges can be achieved through the ideals of Lord Budha, which are and will always remain relevant, Modi said.

Narendra Modi also said, “Today the world fights extra-ordinary challenges. To these challenges, lasting solutions can come from the ideals of Lord Buddha. They were relevant in the past. They are relevant in the present. And, they will remain relevant in the future.”

-RJV/CHK

Global corona cases rise to over 11 million

New Delhi (NVI): The total number of coronavirus cases globally has increased to over 11 million, with over 5,23,000 deaths.

At least 5.7 million patients have recovered worldwide, according to Johns Hopkins University statistics.

In the US, the total number of cases stand around 2.79 million while more than 1,29,400 people have lost their lives due to the deadly virus.

Brazil, the second most affected country from COVID-19 after the US, recorded 42,223 cases within 24-hours and surpassed 1.5 million mark. The country’s death toll stands at 63,174.

Saudi Arabia passed milestone of 200,000 confirmed novel coronavirus cases, weeks before the annual Hajj pilgrimage.

The countries around the world including the US, India, Denmark, and Italy have started the process of lifting the lockdown by easing restrictions despite the number of cases continues to rise.

Meanwhile, emphasising on wearing of face masks and social distancing, the World Health Organisation’s emergencies chief Michael J. Ryan said, “we need to put up a fight now during a peak in the current wave of the coronavirus pandemic, rather than focusing on when a second wave might come.”

-RJV

India’s COVID tally nears 6.5 lakh; death toll 18,655

New Delhi (NVI): The coronavirus cases in India saw the biggest single-day spike of 22,771 in the past 24 hours, taking the total number to 6,48,315, Union Health Ministry confirmed.

The death toll due to the virus rose to 18,655, with 442 new fatalities being reported in the last 24 hours,

As many as 3,94,227 patients have recovered all over the country. With this the recovery rate in India stands at 60.73 percent.

In Maharashtra, the COVID-19 cases increased to 1,92,990, followed by Tamil Nadu with 1,027,21 cases, and Delhi with 94,695 cases.

Maharashtra has also reported the highest number of fatalities at 8376, ministry said.

The death toll in the national capital rose to 2,923, while 65,625 patients in Delhi have recovered so far, the healthy ministry data shows.

The other worst affected states are Gujarat (34,600), Uttar Pradesh (25,797), West Bengal (20,488) and Rajasthan (19,052).

Currently, 5,635 beds are occupied in the hospitals out of a total capacity of 15,243 beds, 1,948 in the dedicated Covid Care Centres and 167 in the dedicated Covid Health Centres. Over 15,878 people are under home isolation.

Meanwhile, the Indian Council of Medical Research (ICMR) said the total number of samples tested up to July 3 is 95,40,132 of which 2,42,383 samples were tested yesterday.

-RJV

Covid-19 cases surpass 8,000 mark in J&K with 170 fresh cases

Over 3,200 cops COVID positive in J&K and 15 succumbed to virus
File photo

Abid Bashir

Srinagar (NVI): The total number of confirmed Covid-19 positive cases today crossed 8,000 mark in Jammu and Kashmir as 170 fresh cases were reported including 10 Beacon men, four CRPF personnel and four minors.

Officials said that among new cases that were detected in J&K, 61 were tested positive at SKIMS, 11 at JVC Bemina and rest at other hospitals. “The total number of Covid positive cases has crossed 8,000. The new 170 cases include 10 Beacon men, four CRPF personnel, a doctor and four minors,” they said.

Among the 170 new cases, 128 belong to Kashmir division while 42 are from Jammu division, officials said, adding that the total number of positive cases in Kashmir has reached 6,327 including 3,721 recoveries and 105 deaths while the total number of positive cases in Jammu has reached 1,692 including 1,254 recoveries and 14 deaths.

The officials said that the total number of active cases in the UT is 2,825 including 2,401 from Kashmir and 424 from Jammu.

With 101 more recoveries, the tally of total recoveries in J&K has reached 5,075 which is 63.28 percent of the total cases.

Cases tested positive in J&K include 41 from Srinagar, 5 from Kulgam, 21 from Baramulla, 1 from Shopian, 21 from Anantnag, 24 from Kupwara, 5 from Budgam, 2 from Bandipora and 8 from Ganderbal in Kashmir division while 42 from Jammu include 13 from Jammu and two from Udhampur, 10 from Kathua, 6 from Samba, 3 each from Ramban, Doda and Rajouri and 2 from Kishtwar.

As per the daily information bulletin, 2,90,760 persons in J&K are under observation while 40,929 persons have been kept under home quarantine. Besides that, 2,825 persons are in hospital isolation while 39 persons are under hospital quarantine.

According to the bulletin, 2,02,112 persons have completed the surveillance period and 44,736 persons are under home surveillance.

So far, results of 3,85,501 samples are available out of which 3,77,482 stand negative while 8,019 have been tested positive. Among positive cases, 2,825 are active and 5,075 persons have recovered while 120 have died.

Odisha: Covid-19 test in private labs fixed at Rs 2,200

Subrat Kumar Sarangi

Bhubaneswar (NVI): The Odisha Government has fixed price for RT-PCR COVID-19 test in private labs for individuals at Rs 2,200, as per a notification by the State Health and Family Welfare department.

Four private hospitals in Bhubaneswar city have also been named in the notification, approved by ICMR for conducting the test.

The test can be conducted at the Department of Lab Services, Apollo Hospital, IMS & SUM Hospital, In DNA Life Sciences Pvt Limited (2 nd Floor, KIIT TBI ), and Gen X Diagnostics, Bhubaneswar.

The tests will be conducted under the supervision of RMRC, Bhubaneswar, the notification said.

Meanwhile, the total confirmed coronavirus cases in Odisha have climbed to 8,106 with 561 new positive cases in the biggest single-day spike so far, according to the state Health and Family Welfare Department.

Out of the new cases detected, 424 were reported from quarantine centres while the rest 136 are local contacts.

Among the fresh cases, 560 positive cases are reported from 19 districts of Odisha and 1 case is that of an NDRF personnel who had returned from West Bengal during Amphan duty.

With two more fatalities reported from Ganjam, the death toll from the disease has climbed to 29 in the state.

The number of active cases in the state currently stands at 2,567. As many as 3,534 patients have recovered from the disease in Odisha so far.

-ARK

JEE and NEET exams postponed, to be held in September

Quality education
Union Minister Ramesh Pokhriyal ‘Nishank’

New Delhi (NVI): Union HRD Minister Ramesh Pokhriyal Nishank today announced that JEE and NEET exams have been postponed while keeping in mind the safety of students amid the Covid-19 pandemic.

In a video message, the HRD minister announced that JEE Main exam will now be held between September 1-6, JEE Advanced exam will be held on Sept 27 and NEET exam will be held on Sept 13.

The announcement comes a day after the HRD Ministry had formed a panel and asked the National Testing Agency (NTA) to give recommendations on the conduct of exams amid the ongoing pandemic situation.

“Keeping in mind the safety of students and to ensure quality education we have decided to postpone #JEE & #NEET examinations. JEE Main examination will be held between 1st-6th Sept, JEE advanced exam will be held on 27th Sept & NEET examination will be held on 13th Sept,” Nishank said in a video message.

This is the second time this year that these exams have been postponed this year. While JEE exam was scheduled to be held in April, NEET was to be held in May.

-ARK

J&K: Govt employee arrested for ‘anti-national’ social media posts

Abid Bashir

Srinagar (NVI): A government employee, working in the higher education department was today arrested by Jammu and Kashmir Police’s Cyber Cell for running an anti-national campaign on social media.

As per the official release, a person identified as Tahir Nazir Shalla, working in the higher education department was arrested for posting the controversial stuff on social media, which as per the police was in contravention of social media policy for the government.

An official in the Cyber Cell said that the employee was allegedly running an anti-national campaign on social media and tried to create a fake narrative. “The accused was circulating highly seditious and provocative posts through his social media accounts, which were highly prejudicial to maintenance of law and order,” he said.

He said that the accused has been handed over to Police Station Sopore in northern district of Baramulla by Cyber Cell. “The employee has also been booked under relevant sections of law for further course of action,” they said.

Meanwhile, Jammu and Kashmir Police’s Cyber Cell said that it has identified many persons who are misusing social media by spreading false propaganda against the government.

The statement further read that the investigation has been set in motion to identify other persons involved in similar anti-State campaigns on social media and spreading false propaganda.

MUST READ